🇺🇸 FDA
Patent

US 10988441

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

granted A61KA61K31/185A61K31/277

Quick answer

US patent 10988441 (Alpha-cinnamide compounds and compositions as HDAC8 inhibitors) held by Valo Early Discovery, Inc. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/185, A61K31/277, A61K31/397, A61K31/4035